Your browser doesn't support javascript.
loading
Determinants of the t(14;18) translocation and their role in t(14;18)-positive follicular lymphoma.
Kelly, Rachel S; Roulland, Sandrine; Morgado, Ester; Sungalee, Stéphanie; Jouve, Nathalie; Tumino, Rosario; Krogh, Vittorio; Panico, Salvatore; Polidoro, Silvia; Masala, Giovanna; Sánchez, María-José; Chirlaque, Maria-Dolores; Sala, Núria; Gurrea, Aurelio Barricarte; Dorronsoro, Miren; Travis, Ruth C; Riboli, Elio; Gunter, Marc; Murphy, Neil; Vermeulen, Roel; Bueno-de-Mesquita, H B; Peeters, Petra H; Trichopoulou, Antonia; Trichopoulos, Dimitrios; Lagiou, Pagona; Nieters, Alexandra; Canzian, Federico; Kaaks, Rudolf; Boeing, Heiner; Weiderpass, Elisabete; Stocks, Tanja; Melin, Beatrice; Overvad, Kim; Tjønneland, Anne; Olsen, Anja; Brennan, Paul; Johansson, Mattias; Nadel, Bertrand; Vineis, Paolo.
Affiliation
  • Kelly RS; MRC/PHE Centre for Environment and Health, School of Public Health, Imperial College London, St Mary's Campus Norfolk Place, London, W2 1PG, UK.
  • Roulland S; Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA.
  • Morgado E; Center of Immunology of Marseille-Luminy (CIML), Université de la Méditerranée, Marseille, France.
  • Sungalee S; INSERM U631, Marseille, France.
  • Jouve N; CNRS UMR6102, Marseille, France.
  • Tumino R; Center of Immunology of Marseille-Luminy (CIML), Université de la Méditerranée, Marseille, France.
  • Krogh V; INSERM U631, Marseille, France.
  • Panico S; CNRS UMR6102, Marseille, France.
  • Polidoro S; Center of Immunology of Marseille-Luminy (CIML), Université de la Méditerranée, Marseille, France.
  • Masala G; INSERM U631, Marseille, France.
  • Sánchez MJ; CNRS UMR6102, Marseille, France.
  • Chirlaque MD; Center of Immunology of Marseille-Luminy (CIML), Université de la Méditerranée, Marseille, France.
  • Sala N; INSERM U631, Marseille, France.
  • Gurrea AB; CNRS UMR6102, Marseille, France.
  • Dorronsoro M; Cancer Registry and Histopathology Unit, "Civic - M.P.Arezzo" Hospital, ASP Ragusa, Ragusa, Italy.
  • Travis RC; Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Riboli E; Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy.
  • Gunter M; HuGeF - Human Genetics Foundation, Turin, Italy.
  • Murphy N; Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy.
  • Vermeulen R; Escuela Andaluza de Salud Pública, Instituto de Investigación Biosanitaria de Granada (Granada.ibs), Granada, Spain.
  • Bueno-de-Mesquita HB; CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
  • Peeters PH; CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
  • Trichopoulou A; Department of Epidemiology, Murcia Regional Health Authority, Murcia, Spain.
  • Trichopoulos D; Unit of Nutrition and Cancer, Cancer Epidemiology Research Program and Translational Research Laboratory, Catalan Institute of Oncology (IDIBELL), Barcelona, Spain.
  • Lagiou P; CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
  • Nieters A; Navarre Public Health Institute, Pamplona, Spain.
  • Canzian F; Public Health Direction and Ciberesp-Biodonostia Basque Regional Health Department, Vitoria, Spain.
  • Kaaks R; Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
  • Boeing H; MRC/PHE Centre for Environment and Health, School of Public Health, Imperial College London, St Mary's Campus Norfolk Place, London, W2 1PG, UK.
  • Weiderpass E; MRC/PHE Centre for Environment and Health, School of Public Health, Imperial College London, St Mary's Campus Norfolk Place, London, W2 1PG, UK.
  • Stocks T; MRC/PHE Centre for Environment and Health, School of Public Health, Imperial College London, St Mary's Campus Norfolk Place, London, W2 1PG, UK.
  • Melin B; Division of Environmental Epidemiology, Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands.
  • Overvad K; Department for Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
  • Tjønneland A; Department of Gastroenterology and Hepatology, University Medical Centre, Utrecht, The Netherlands.
  • Olsen A; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, 3508 GA, Utrecht, The Netherlands.
  • Brennan P; Hellenic Health Foundation, 13 Kaisareias Street, 115 27, Athens, Greece.
  • Johansson M; Bureau of Epidemiologic Research, Academy of Athens, 23 Alexandroupoleos Street, 115 27, Athens, Greece.
  • Nadel B; Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA.
  • Vineis P; Hellenic Health Foundation, 13 Kaisareias Street, 115 27, Athens, Greece.
Cancer Causes Control ; 26(12): 1845-55, 2015 Dec.
Article in En | MEDLINE | ID: mdl-26424368
ABSTRACT

PURPOSE:

The strong association between t(14;18) translocation and follicular lymphoma (FL) is well known. However, the determinants of this chromosomal aberration and their role in t(14;18) associated FL remain to be established.

METHODS:

t(14;18) frequency within the B cell lymphoma 2 major breakpoint region was determined for 135 incident FL cases and 251 healthy controls as part of a nested case-control study within the European Prospective Investigation into Cancer cohort. Quantitative real-time PCR was performed in DNA extracted from blood samples taken at recruitment. The relationship between prevalence and frequency of the translocation with baseline anthropometric, lifestyle, and dietary factors in cases and controls was determined. Unconditional logistic regression was used to explore whether the risk of FL associated with these factors differed in t(14;18)(+) as compared to t(14;18)(-) cases.

RESULTS:

Among incident FL cases, educational level (χ(2) p = 0.021) and height (χ(2) p = 0.025) were positively associated with t(14;18) prevalence, and cases with high frequencies [t(14;18)(HF)] were significantly taller (t test p value = 0.006). These findings were not replicated in the control population, although there were a number of significant associations with dietary variables. Further analyses revealed that height was a significant risk factor for t(14;18)(+) FL [OR 6.31 (95% CI 2.11, 18.9) in the tallest versus the shortest quartile], but not t(14;18)(-) cases.

CONCLUSIONS:

These findings suggest a potential role for lifestyle factors in the prevalence and frequency of the t(14;18) translocation. The observation that the etiology of FL may differ by t(14;18) status, particularly with regard to height, supports the subdivision of FL by translocation status.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Translocation, Genetic / Chromosomes, Human, Pair 14 / Chromosomes, Human, Pair 18 / Lymphoma, Follicular Type of study: Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Causes Control Journal subject: EPIDEMIOLOGIA / NEOPLASIAS Year: 2015 Type: Article Affiliation country: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Translocation, Genetic / Chromosomes, Human, Pair 14 / Chromosomes, Human, Pair 18 / Lymphoma, Follicular Type of study: Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Causes Control Journal subject: EPIDEMIOLOGIA / NEOPLASIAS Year: 2015 Type: Article Affiliation country: United kingdom